SynRx Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.1M

  • Investors
  • 5

SynRx Therapeutics General Information

Description

Developer of innovative drugs designed for DNA damage repair (DDR). The company focuses on the development of novel anti-tumor drugs using synthetic lethality approaches, providing medical industry users with effective oncology solutions.

Contact Information

Website
www.synrx.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 201, Building 4, Number 1390 Cangxing Street, Cangqian Subdistrict
  • Yuhang District
  • Hangzhou, Zhejiang 311121
  • China
+86 0571
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 201, Building 4, Number 1390 Cangxing Street, Cangqian Subdistrict
  • Yuhang District
  • Hangzhou, Zhejiang 311121
  • China
+86 0571

SynRx Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynRx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 08-Dec-2025 $14.1M Completed Generating Revenue
5. Secondary Transaction - Private 12-Nov-2025 Completed Generating Revenue
4. Early Stage VC 11-Apr-2023 Completed Generating Revenue
3. Early Stage VC 17-Oct-2022 Completed Generating Revenue
2. Secondary Transaction - Private 29-Apr-2022 Completed Generating Revenue
1. Secondary Transaction - Private 21-Dec-2021 Completed Generating Revenue
To view SynRx Therapeutics’s complete valuation and funding history, request access »

SynRx Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhejiang Innovation Industry PE/Buyout Minority
Hangzhou Bejia Investment Management Growth/Expansion Minority
Lapam Capital Venture Capital Minority
Zhejiang Haibang Fenghua Investment Management Venture Capital Minority
HaiBang Ventures Venture Capital Minority
To view SynRx Therapeutics’s complete investors history, request access »

SynRx Therapeutics FAQs

  • When was SynRx Therapeutics founded?

    SynRx Therapeutics was founded in 2021.

  • Where is SynRx Therapeutics headquartered?

    SynRx Therapeutics is headquartered in Hangzhou, China.

  • What industry is SynRx Therapeutics in?

    SynRx Therapeutics’s primary industry is Drug Discovery.

  • Is SynRx Therapeutics a private or public company?

    SynRx Therapeutics is a Private company.

  • What is SynRx Therapeutics’s current revenue?

    The current revenue for SynRx Therapeutics is .

  • How much funding has SynRx Therapeutics raised over time?

    SynRx Therapeutics has raised $28.1M.

  • Who are SynRx Therapeutics’s investors?

    Zhejiang Innovation Industry, Hangzhou Bejia Investment Management, Lapam Capital, Zhejiang Haibang Fenghua Investment Management, and HaiBang Ventures have invested in SynRx Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process